3-deazaneplanocin has been researched along with B-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpa, CA; Beule, D; Capper, D; Dettmer, K; Dimitrova, L; Hummel, M; Kleo, K; Lenze, D; López, C; Messerschmidt, C; Oefner, PJ; Oehl-Huber, K; Oker, E; Schoeler, A; Siebert, R; Tomaszewski, N; Wagener, R | 1 |
| Berkova, Z; Braun, FK; Chandra, J; Mathur, R; Samaniego, F; Sehgal, L; Wilkie-Grantham, R | 1 |
2 other study(ies) available for 3-deazaneplanocin and B-Cell Lymphoma
| Article | Year |
|---|---|
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.
Topics: Adenosine; Adenosylhomocysteinase; Apoptosis; Cell Proliferation; DNA Copy Number Variations; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Humans; Lymphoma, B-Cell; Tumor Cells, Cultured | 2020 |
Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.
Topics: Adenosine; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cells, Cultured; Humans; Lymphoma, B-Cell; Methyltransferases; Proteolysis; TNF-Related Apoptosis-Inducing Ligand | 2015 |